NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients (2019)
- Authors:
- USP affiliated authors: LEITE, KATIA RAMOS MOREIRA - FM ; BRENTANI, HELENA PAULA - FM ; CHAMMAS, ROGER - FM
- Unidade: FM
- DOI: 10.1038/s41523-019-0106-x
- Subjects: NEOPLASIAS MAMÁRIAS; METÁSTASE NEOPLÁSICA; BIOMARCADORES; METILAÇÃO DE DNA; PROTO-ONCOGENES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Npj breast cancer
- ISSN: 2374-4677
- Volume/Número/Paginação/Ano: v. 5, article ID 11, 12p, 2019
- Este periódico possui versão em acesso aberto
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão: publishedVersion
- Licença: cc-by
- Evidência: deprecated
- Status do Acesso Aberto: gold
-
ABNT
JANDREY, Elisa H. F et al. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. Npj breast cancer, v. 5, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41523-019-0106-x. Acesso em: 10 mar. 2026. -
APA
Jandrey, E. H. F., Moura, R. P., Andrade, L. N. S., Machado, C. L., Campesato, L. F., Leite, K. R. M., et al. (2019). NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients. Npj breast cancer, 5. doi:10.1038/s41523-019-0106-x -
NLM
Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, Brentani HP, Chammas R. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients [Internet]. Npj breast cancer. 2019 ; 5[citado 2026 mar. 10 ] Available from: https://doi.org/10.1038/s41523-019-0106-x -
Vancouver
Jandrey EHF, Moura RP, Andrade LNS, Machado CL, Campesato LF, Leite KRM, Inoue LT, Asprino PF, Brentani HP, Chammas R. NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients [Internet]. Npj breast cancer. 2019 ; 5[citado 2026 mar. 10 ] Available from: https://doi.org/10.1038/s41523-019-0106-x - Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection?[Carta]
- Why do we keep reporting high-grade prostatic intraepithelial neoplasia (HGPIN)? [Editorial]
- Low-grade prostate cancer should still be labelled cancer Comment. [Editorial]
- The International Society of Urological Pathology Education weba web-based system for training and testing of pathologists
- Utility of Pathology Imagebase for standardisation of prostate cancer grading
- Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
- Study of kidney morphologic and structural changes related to different ischemia times and types of clamping of the renal vascular pedicle
- Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System
- Pathology Imagebase-a reference image database for standardization of pathology
- Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
